ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical ... - BioMedReports (subscription) PDF Print
BioMedReports (subscription)
By PR Newswire: Biotechnology CCR2 inhibition in diabetic mice resulted in rapid and robust improvements of albuminuria, serum markers of renal function, and hyperglycemia. These data were highlighted today in a poster presentation titled "CCR2 ...
ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.